FOLH1 and prostate cancer: Mazzocco et al. [86] developed an orthotopic model generated by injecting LNCaP cells into the prostate to evaluate a fluorescent-labeled scFv of the anti-PSMA antibody, scFvD2B, as a specific probe for the detection of prostate cancer by in vivo fluorescence imaging.